The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Degradation of neutrophil extracellular traps is decreased in patients with antiphospholipid syndrome.

Author

Summary, in English

A decreased ability to degrade neutrophil extracellular traps (NETs) is seen in a subgroup of patients with systemic lupus erythematosus (SLE) and correlates with the presence of autoantibodies. Antiphospholipid syndrome (APS) can develop secondary to SLE or as a primary disease. In the current study we investigated the ability of sera from patients with APS to degrade NETs. The presence of antibodies against NETs and neutrophil remnants were also determined in the same patients.

Department/s

Publishing year

2014

Language

English

Pages

66-70

Publication/Series

Clinical and Experimental Rheumatology

Volume

32

Issue

1

Document type

Journal article

Publisher

Pacini

Topic

  • Rheumatology and Autoimmunity

Status

Published

Research group

  • Protein Chemistry, Malmö

ISBN/ISSN/Other

  • ISSN: 1593-098X